Most Popular

UK: Inflexion closes Buyout Fund VII at hard cap of €4.5bn

European mid-market private equity firm Inflexion has announced the final close of Inflexion Buyout Fund VII at its hard cap of €4.5bn (US$5.2bn) after six months in the market, surpassing its initial target of €3.75bn. “Closing the fund so swiftly in the current fundraising environment is a testament to the...

UK: Prescient strengthens pricing and market access capabilities with Dolon

Prescient Healthcare Group, a UK-based product strategy consultancy to the global biopharmaceutical industry, has acquired London-based pricing and market access consultancy Dolon, strengthening its ability to support global biopharma companies navigating increasingly complex and interconnected clinical, commercial and market access environments. The deal enhances the breadth of Prescient’s offer to the market and represents the next step in the firm’s growth journey. It follows on from the acquisition of healthcare consultancy Uptake Strategies earlier this year. “Dolon brings deep strategic pricing and market access expertise and a strong cultural alignment that makes this...